VNDA position history
The shares of Vanda Pharmaceuticals (VNDA) that Krensavage Asset Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q3: 312,299 shares, $3.1M, 0.98% of portfolio, New
- 2022 Q4: 345,290 shares, $2.6M, 0.79% of portfolio, Add +10.6%
- 2023 Q1: 361,560 shares, $2.5M, 0.75% of portfolio, Add +4.7%
- 2023 Q2: 362,951 shares, $2.4M, 0.76% of portfolio, Add +0.4%
- 2023 Q3: 360,429 shares, $1.6M, 0.57% of portfolio, Reduce −0.7%
- 2023 Q4: not held, Exit
- 2024 Q1: not held
- 2024 Q2: 662,166 shares, $3.7M, 1.7% of portfolio, New
- 2024 Q3: 414,684 shares, $1.9M, 1.1% of portfolio, Reduce −37.4%
- 2024 Q4: 479,094 shares, $3.6M, 2.1% of portfolio, Add +15.5%
- 2025 Q1: 754,381 shares, $3.5M, 1.9% of portfolio, Add +57.5%
- 2025 Q2: 1,024,883 shares, $4.8M, 2.6% of portfolio, Add +35.9%
- 2025 Q3: 1,180,388 shares, $5.9M, 2.5% of portfolio, Add +15.2%
- 2025 Q4: 1,180,388 shares, $10M, 3.7% of portfolio
- 2026 Q1: 1,180,388 shares, $8.2M, 3.2% of portfolio
- 2026 Q2: 1,180,388 shares, $7.2M, 2.7% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|